Q1 2026 · 13F-HR
Seven Fleet Capital Management LPholdings as filed
Filed 2026-05-15 · accession 0001013594-26-000616
$315.1M
Reported value
114
Positions
2026-03-31
Period end
The Brief · Seven Fleet Capital Management LP · Q1 2026
AI · grounded in 13F
Seven Fleet Capital Management LP established a new position in CG ONCOLOGY INC valued at $97.4M. The fund also opened a new position in IPSC for $6.7M and increased its holdings in TNGX by 133.3%. On the sell side, the fund closed its position in EXEL, reducing its exposure by $3.0M.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 156944101 | CGON | CG ONCOLOGY INC | $97.4M | 30.9% | 1,439,393 | Common | SHARED |
| 87583X109 | TNGX | TANGO THERAPEUTICS INC | $10.5M | 3.33% | 502,012 | Common | SOLE |
| 76155X100 | RVMD | REVOLUTION MEDICINES INC | $7.9M | 2.49% | 80,792 | Common | SOLE |
| 90240B106 | TYRA | TYRA BIOSCIENCES INC | $7.5M | 2.38% | 195,685 | Common | SOLE |
| 53635D202 | LQDA | LIQUIDIA CORPORATION | $7.1M | 2.25% | 187,876 | Common | SOLE |
| 00847X104 | AGIO | AGIOS PHARMACEUTICALS INC | $7.1M | 2.25% | 209,547 | Common | SOLE |
| 15673T100 | IPSC | CENTURY THERAPEUTICS INC | $6.7M | 2.11% | 2,947,826 | Common | SOLE |
| 29337E102 | ELVN | ENLIVEN THERAPEUTICS INC | $6.4M | 2.04% | 164,030 | Common | SOLE |
| 92243G108 | PCVX | VAXCYTE INC | $6.3M | 2.00% | 108,450 | Common | SOLE |
| 87583X110 | TNGX | TANGO THERAPEUTICS INC | $6.3M | 2.00% | 300,648 | Common | SHARED |
| 19240Q201 | COGT | COGENT BIOSCIENCES INC | $5.8M | 1.82% | 149,399 | Common | SOLE |
| 05338F307 | AVTX | AVALO THERAPEUTICS INC | $5.4M | 1.71% | 360,064 | Common | SHARED |
| 603380206 | NERV | MINERVA NEUROSCIENCES INC | $5.4M | 1.70% | 889,254 | Common | SHARED |
| 156944100 | CGON | CG ONCOLOGY INC | $5.1M | 1.63% | 75,758 | Common | SOLE |
| N69605108 | PHVS | PHARVARIS N V | $4.9M | 1.55% | 172,731 | Common | SOLE |
| 00370M103 | ABVX | ABIVAX SA | $4.8M | 1.52% | 43,052 | Common | SOLE |
| 252828108 | DNTH | DIANTHUS THERAPEUTICS INC | $4.6M | 1.45% | 54,258 | Common | SOLE |
| N69605109 | — | PHARVARIS N V | $4.1M | 1.29% | 143,966 | Common | SHARED |
| 23282W605 | CYTK | CYTOKINETICS INC | $4.0M | 1.28% | 61,269 | Common | SOLE |
| 834203309 | SLNO | SOLENO THERAPEUTICS INC | $3.9M | 1.23% | 115,770 | Common | SOLE |
| 29337E103 | ELVN | ENLIVEN THERAPEUTICS INC | $3.7M | 1.19% | 95,253 | Common | SHARED |
| 29479A108 | ERAS | ERASCA INC | $3.6M | 1.14% | 222,468 | Common | SOLE |
| G76279101 | ROIV | ROIVANT SCIENCES LTD | $3.6M | 1.13% | 128,168 | Common | SOLE |
| 23284F106 | CTMX | CYTOMX THERAPEUTICS INC. | $3.4M | 1.07% | 714,000 | Common | SHARED |
| 05338F306 | AVTX | AVALO THERAPEUTICS INC | $3.2M | 1.01% | 213,819 | Common | SOLE |
| 29842P105 | EPRX | EUPRAXIA PHARMACEUTICALS INC | $3.1M | 1.00% | 433,515 | Common | SOLE |
| 45166A102 | IDYA | IDEAYA BIOSCIENCES INC | $2.9M | 0.91% | 86,283 | Common | SOLE |
| 877619106 | TSHA | TAYSHA GENE THERAPIES INC | $2.8M | 0.89% | 625,708 | Common | SOLE |
| 04351P101 | ASNDUSD | ASCENDIS PHARMA A/S | $2.8M | 0.88% | 12,179 | Common | SOLE |
| 20454B104 | CMPX | COMPASS THERAPEUTICS INC | $2.7M | 0.87% | 516,972 | Common | SOLE |
| 36322Q206 | DMRA | DAMORA THERAPEUTICS INC | $2.6M | 0.83% | 101,248 | Common | SOLE |
| 483497103 | KALV | KALVISTA PHARMACEUTICALS INC | $2.6M | 0.82% | 128,487 | Common | SOLE |
| 75943R102 | RLAY | RELAY THERAPEUTICS INC | $2.6M | 0.81% | 257,738 | Common | SOLE |
| 05464T104 | AXSM | AXSOME THERAPEUTICS INC. | $2.4M | 0.75% | 14,055 | Common | SOLE |
| 20454B105 | CMPX | COMPASS THERAPEUTICS INC | $2.2M | 0.71% | 423,566 | Common | SHARED |
| 252828109 | DNTH | DIANTHUS THERAPEUTICS INC | $2.2M | 0.71% | 26,551 | Common | SHARED |
| 29842P106 | EPRX | EUPRAXIA PHARMACEUTICALS INC | $2.0M | 0.63% | 276,000 | Common | SHARED |
| 24477V105 | DFTX | DEFINIUM THERAPEUTICS INC | $1.9M | 0.60% | 99,887 | Common | SOLE |
| 603170101 | MLYS | MINERALYS THERAPEUTICS INC | $1.9M | 0.60% | 69,571 | Common | SOLE |
| 834203310 | SLNO | SOLENO THERAPEUTICS INC | $1.8M | 0.57% | 54,000 | Common | SHARED |
| 558868105 | MDGL | MADRIGAL PHARMACEUTICALS INC | $1.8M | 0.56% | 3,393 | Common | SOLE |
| 23284F105 | CTMX | CYTOMX THERAPEUTICS INC. | $1.7M | 0.55% | 371,398 | Common | SOLE |
| 04746L203 | LONA | LEONABIO INC | $1.7M | 0.54% | 164,676 | Common | SOLE |
| 805111101 | SVRA | SAVARA INC | $1.6M | 0.51% | 295,688 | Common | SOLE |
| 46489V302 | CATX | PERSPECTIVE THERAPEUTICS INC | $1.6M | 0.50% | 379,082 | Common | SOLE |
| 045396207 | ASMB | ASSEMBLY BIOSCIENCES INC | $1.6M | 0.49% | 56,147 | Common | SOLE |
| 78397T203 | SABS | SAB BIOTHERAPEUTICS INC | $1.5M | 0.49% | 400,000 | Common | SHARED |
| 603380205 | NERV | MINERVA NEUROSCIENCES INC | $1.5M | 0.48% | 248,476 | Common | SOLE |
| 98887Q104 | ZLAB | ZAI LAB LTD | $1.5M | 0.46% | 77,858 | Common | SOLE |
| 87650L103 | TARS | TARSUS PHARMACEUTICALS INC | $1.4M | 0.44% | 19,800 | Common | SOLE |
| 221015100 | CRVS | CORVUS PHARMACEUTICALS INC | $1.2M | 0.38% | 82,890 | Common | SOLE |
| 92243G109 | PCVX | VAXCYTE INC | $1.2M | 0.37% | 20,000 | Common | SHARED |
| 04272N102 | AVBP | ARRIVENT BIOPHARMA INC | $1.2M | 0.37% | 50,252 | Common | SOLE |
| 517125100 | LRMR | LARIMAR THERAPEUTICS INC | $1.2M | 0.37% | 256,585 | Common | SOLE |
| 501147102 | KRYS | KRYSTAL BIOTECH INC | $1.1M | 0.35% | 4,316 | Common | SOLE |
| 46124U107 | IVA | INVENTIVA SA | $1.1M | 0.35% | 200,141 | Common | SOLE |
| 53630X203 | LPCN | LIPOCINE INC NEW | $998,287 | 0.32% | 124,942 | Common | SOLE |
| 00773J202 | SYRE | SPYRE THERAPEUTICS INC | $993,164 | 0.32% | 19,690 | Common | SOLE |
| 09058V103 | BCRX | BIOCRYST PHARMACEUTICALS INC | $975,733 | 0.31% | 102,493 | Common | SOLE |
| 98401F105 | XNCR | XENCOR INC | $964,800 | 0.31% | 80,000 | Common | SOLE |
| 15117B202 | CLDX | CELLDEX THERAPEUTICS INC NEW | $929,396 | 0.29% | 29,300 | Common | SOLE |
| 76029N106 | REPL | REPLIMUNE GROUP INC | $921,060 | 0.29% | 120,400 | Common | SOLE |
| 578784100 | MAZE | MAZE THERAPEUTICS INC | $916,604 | 0.29% | 30,707 | Common | SOLE |
| 28658R106 | CLYM | CLIMB BIO INC | $894,980 | 0.28% | 130,654 | Common | SOLE |
| 20451W101 | CMPS | COMPASS PATHWAYS PLC | $873,856 | 0.28% | 158,021 | Common | SOLE |
| G01767105 | ALKS | ALKERMES PLC | $854,651 | 0.27% | 24,170 | Common | SOLE |
| 82686Q101 | SLN | SILENCE THERAPEUTICS PLC | $826,120 | 0.26% | 156,759 | Common | SOLE |
| 21833P301 | CRBP | CORBUS PHARMACEUTICALS HLDGS | $804,601 | 0.26% | 85,687 | Common | SOLE |
| 15102K100 | CELC | CELCUITY INC | $684,840 | 0.22% | 6,000 | Common | SOLE |
| 037326105 | ANTX | AN2 THERAPEUTICS INC | $682,977 | 0.22% | 199,701 | Common | SOLE |
| 24823R105 | DNLI | DENALI THERAPEUTICS INC | $677,491 | 0.22% | 35,286 | Common | SOLE |
| 91307C102 | UTHR | UNITED THERAPEUTICS RP DEL | $668,881 | 0.21% | 1,128 | Common | SOLE |
| 532457108 | LLY | ELI LILLY & CO | $662,234 | 0.21% | 720 | Common | SOLE |
| 92337C203 | VSTM | VERASTEM INC | $654,020 | 0.21% | 123,400 | Common | SOLE |
| 53635D203 | LQDA | LIQUIDIA CORPORATION | $641,580 | 0.20% | 17,000 | Common | SHARED |
| 374163103 | GERN | GERON CORP | $632,028 | 0.20% | 424,180 | Common | SOLE |
| 67577R102 | IRD | OPUS GENETICS INC | $610,801 | 0.19% | 134,242 | Common | SOLE |
| 45719W205 | IKT | INHIBIKASE THERAPEUTICS INC | $547,008 | 0.17% | 325,600 | Common | SOLE |
| 21077P108 | CNTX | CONTEXT THERAPEUTICS INC | $499,857 | 0.16% | 190,785 | Common | SOLE |
| 10919W405 | DRUG | BRIGHT MINDS BIOSCIENCES INC | $466,644 | 0.15% | 6,395 | Common | SOLE |
| 92915B106 | VYGR | VOYAGER THERAPEUTICS INC | $444,684 | 0.14% | 115,203 | Common | SOLE |
| 86366E106 | GPCR | STRUCTURE THERAPEUTICS INC | $433,800 | 0.14% | 9,000 | Common | SOLE |
| 74366E102 | PTGX | PROTAGONIST THERAPEUTICS INC | $421,600 | 0.13% | 4,000 | Common | SOLE |
| G72800108 | PRTA | PROTHENA CORP PLC | $420,876 | 0.13% | 43,300 | Common | SOLE |
| 45826J105 | NTLA | INTELLIA THERAPEUTICS INC | $403,830 | 0.13% | 31,500 | Common | SOLE |
| 59935V107 | MIST | MILESTONE PHARMACEUTICALS IN | $396,666 | 0.13% | 333,333 | Common | SOLE |
| 78397T202 | SABS | SAB BIOTHERAPEUTICS INC | $383,000 | 0.12% | 100,000 | Common | SOLE |
| 696389402 | PALI | PALISADE BIO INC | $372,925 | 0.12% | 213,100 | Common | SOLE |
| 61225M102 | GLUE | MONTE ROSA THERAPEUTICS INC | $370,619 | 0.12% | 22,530 | Common | SOLE |
| 28036F105 | EWTX | EDGEWISE THERAPEUTICS INC | $368,582 | 0.12% | 11,701 | Common | SOLE |
| 90466Y202 | UNCY | UNICYCIVE THERAPEUTICS INC | $366,506 | 0.12% | 55,700 | Common | SOLE |
| 21217B100 | CTNM | CONTINEUM THERAPEUTICS INC | $353,325 | 0.11% | 27,054 | Common | SOLE |
| 89532M101 | TRVI | TREVI THERAPEUTICS INC | $323,887 | 0.10% | 27,149 | Common | SOLE |
| 30052C107 | EOLS | EVOLUS INC | $320,814 | 0.10% | 78,057 | Common | SOLE |
| 640268306 | NKTR | NEKTAR THERAPEUTICS | $309,385 | 0.10% | 4,300 | Common | SOLE |
| 359616109 | FULC | FULCRUM THERAPEUTICS INC | $292,227 | 0.09% | 38,100 | Common | SOLE |
| 81734D104 | SEPN | SEPTERNA INC | $275,023 | 0.09% | 11,445 | Common | SOLE |
| 67576A100 | OCUL | OCULAR THERAPEUTIX INC | $265,077 | 0.08% | 31,296 | Common | SOLE |
| 98943L107 | ZNTL | ZENTALIS PHARMACEUTICALS INC | $257,400 | 0.08% | 110,000 | Common | SOLE |
| 03237H101 | AMLX | AMYLYX PHARMACEUTICALS INC | $231,727 | 0.07% | 16,671 | Common | SOLE |
| M40527109 | ENTX | ENTERA BIO LTD | $228,152 | 0.07% | 205,542 | Common | SOLE |
| 670703107 | NUVL | NUVALENT NC | $212,276 | 0.07% | 2,072 | Common | SOLE |
| 07373V105 | BEAM | BEAM THERAPEUTICS INC | $209,800 | 0.07% | 8,804 | Common | SOLE |
| 254604101 | IRON | DISC MEDICINE INC | $206,590 | 0.07% | 3,231 | Common | SOLE |
| 00032Q104 | WHWK | WHITEHAWK THERAPEUTICS INC | $187,321 | 0.06% | 54,296 | Common | SOLE |
| 45720N103 | INBX | INHIBRX BIOSCIENCES INC | $166,865 | 0.05% | 2,482 | Common | SOLE |
| 03770N101 | APGE | APOGEE THERAPEUTICS INC | $165,731 | 0.05% | 1,969 | Common | SOLE |
| 12529R107 | CCCC | C4 THERAPEUTICS INC | $150,110 | 0.05% | 57,076 | Common | SOLE |
| 74346M505 | PMN | PROMIS NEUROSCIENCES INC | $134,620 | 0.04% | 10,600 | Common | SOLE |
| 90240B107 | TYRA | TYRA BIOSCIENCES INC | $111,070 | 0.04% | 2,900 | Common | SHARED |
| 713317105 | PEPG | PEPGEN INC | $105,315 | 0.03% | 59,500 | Common | SOLE |
| 69353Y103 | PMVP | PMV PHARMACEUTICALS INC | $78,738 | 0.02% | 63,498 | Common | SOLE |
| 556099109 | MGNX | MACROGENICS INC | $38,688 | 0.01% | 13,387 | Common | SOLE |
| 230031106 | CGEM | CULLINAN THERAPEUTICS INC | $26,203 | 0.01% | 1,844 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.